Small GTP-binding protein Rho-mediated signaling promotes proliferation of rheumatoid synovial fibroblasts.

Shingo Nakayamada, Hitoshi Kurose, Kazuyoshi Saito, Akira Mogami, Yoshiya Tanaka

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Rho is a major small GTP-binding protein that is involved in the regulation of various cell functions, including proliferation and cell migration, through activation of multiple signaling molecules in various types of cells. We studied its roles in synovial fibroblasts (SFs) in patients with rheumatoid arthritis (RA) and clarified its relevance to RA synovitis, with the following results. 1)We found that the thrombin receptor was overexpressed on RA synovial fibroblasts (RA SFs) and that thrombin induced a marked proliferation and progression of the cell cycle to the S phase in these cells. 2)We also found that thrombin efficiently activated Rho. 3)Rho activation and proliferation and the progression of the cell cycle to the S phase were completely blocked by p115RGS (an N-terminal regulator of the G-protein signaling domain of p115RhoGEF) and by the C-terminal fragments of Galpha13 (an inhibitor of the interaction of receptors with G13). 4)Thrombin induced the secretion of IL-6 by RA SFs, but this action was blocked by p115RGS or Galpha13. Our findings show that the actions of thrombin on the proliferation of RA SFs, cell-cycle progression to the S phase, and IL-6 secretion were mainly mediated by the G13 and RhoGEF pathways. These results suggest that p115RGS and Galpha13 could be potent inhibitors of such functions. A rational design of future therapeutic strategies for RA synovitis could perhaps include the exploitation of the Rho pathway to directly reduce the growth of synovial cells.

Original languageEnglish
JournalArthritis research & therapy
Volume7
Issue number3
Publication statusPublished - Jan 1 2005
Externally publishedYes

Fingerprint

rho GTP-Binding Proteins
Rheumatoid Arthritis
Fibroblasts
Thrombin
Rho Guanine Nucleotide Exchange Factors
S Phase
Cell Cycle
Synovitis
GTP-Binding Proteins
Interleukin-6
Thrombin Receptors
Cell Movement
Growth

All Science Journal Classification (ASJC) codes

  • Rheumatology
  • Immunology and Allergy
  • Immunology

Cite this

Small GTP-binding protein Rho-mediated signaling promotes proliferation of rheumatoid synovial fibroblasts. / Nakayamada, Shingo; Kurose, Hitoshi; Saito, Kazuyoshi; Mogami, Akira; Tanaka, Yoshiya.

In: Arthritis research & therapy, Vol. 7, No. 3, 01.01.2005.

Research output: Contribution to journalArticle

Nakayamada, Shingo ; Kurose, Hitoshi ; Saito, Kazuyoshi ; Mogami, Akira ; Tanaka, Yoshiya. / Small GTP-binding protein Rho-mediated signaling promotes proliferation of rheumatoid synovial fibroblasts. In: Arthritis research & therapy. 2005 ; Vol. 7, No. 3.
@article{f106bcafb59844ca8a816dde62f55595,
title = "Small GTP-binding protein Rho-mediated signaling promotes proliferation of rheumatoid synovial fibroblasts.",
abstract = "Rho is a major small GTP-binding protein that is involved in the regulation of various cell functions, including proliferation and cell migration, through activation of multiple signaling molecules in various types of cells. We studied its roles in synovial fibroblasts (SFs) in patients with rheumatoid arthritis (RA) and clarified its relevance to RA synovitis, with the following results. 1)We found that the thrombin receptor was overexpressed on RA synovial fibroblasts (RA SFs) and that thrombin induced a marked proliferation and progression of the cell cycle to the S phase in these cells. 2)We also found that thrombin efficiently activated Rho. 3)Rho activation and proliferation and the progression of the cell cycle to the S phase were completely blocked by p115RGS (an N-terminal regulator of the G-protein signaling domain of p115RhoGEF) and by the C-terminal fragments of Galpha13 (an inhibitor of the interaction of receptors with G13). 4)Thrombin induced the secretion of IL-6 by RA SFs, but this action was blocked by p115RGS or Galpha13. Our findings show that the actions of thrombin on the proliferation of RA SFs, cell-cycle progression to the S phase, and IL-6 secretion were mainly mediated by the G13 and RhoGEF pathways. These results suggest that p115RGS and Galpha13 could be potent inhibitors of such functions. A rational design of future therapeutic strategies for RA synovitis could perhaps include the exploitation of the Rho pathway to directly reduce the growth of synovial cells.",
author = "Shingo Nakayamada and Hitoshi Kurose and Kazuyoshi Saito and Akira Mogami and Yoshiya Tanaka",
year = "2005",
month = "1",
day = "1",
language = "English",
volume = "7",
journal = "Arthritis Research and Therapy",
issn = "1478-6354",
publisher = "BioMed Central",
number = "3",

}

TY - JOUR

T1 - Small GTP-binding protein Rho-mediated signaling promotes proliferation of rheumatoid synovial fibroblasts.

AU - Nakayamada, Shingo

AU - Kurose, Hitoshi

AU - Saito, Kazuyoshi

AU - Mogami, Akira

AU - Tanaka, Yoshiya

PY - 2005/1/1

Y1 - 2005/1/1

N2 - Rho is a major small GTP-binding protein that is involved in the regulation of various cell functions, including proliferation and cell migration, through activation of multiple signaling molecules in various types of cells. We studied its roles in synovial fibroblasts (SFs) in patients with rheumatoid arthritis (RA) and clarified its relevance to RA synovitis, with the following results. 1)We found that the thrombin receptor was overexpressed on RA synovial fibroblasts (RA SFs) and that thrombin induced a marked proliferation and progression of the cell cycle to the S phase in these cells. 2)We also found that thrombin efficiently activated Rho. 3)Rho activation and proliferation and the progression of the cell cycle to the S phase were completely blocked by p115RGS (an N-terminal regulator of the G-protein signaling domain of p115RhoGEF) and by the C-terminal fragments of Galpha13 (an inhibitor of the interaction of receptors with G13). 4)Thrombin induced the secretion of IL-6 by RA SFs, but this action was blocked by p115RGS or Galpha13. Our findings show that the actions of thrombin on the proliferation of RA SFs, cell-cycle progression to the S phase, and IL-6 secretion were mainly mediated by the G13 and RhoGEF pathways. These results suggest that p115RGS and Galpha13 could be potent inhibitors of such functions. A rational design of future therapeutic strategies for RA synovitis could perhaps include the exploitation of the Rho pathway to directly reduce the growth of synovial cells.

AB - Rho is a major small GTP-binding protein that is involved in the regulation of various cell functions, including proliferation and cell migration, through activation of multiple signaling molecules in various types of cells. We studied its roles in synovial fibroblasts (SFs) in patients with rheumatoid arthritis (RA) and clarified its relevance to RA synovitis, with the following results. 1)We found that the thrombin receptor was overexpressed on RA synovial fibroblasts (RA SFs) and that thrombin induced a marked proliferation and progression of the cell cycle to the S phase in these cells. 2)We also found that thrombin efficiently activated Rho. 3)Rho activation and proliferation and the progression of the cell cycle to the S phase were completely blocked by p115RGS (an N-terminal regulator of the G-protein signaling domain of p115RhoGEF) and by the C-terminal fragments of Galpha13 (an inhibitor of the interaction of receptors with G13). 4)Thrombin induced the secretion of IL-6 by RA SFs, but this action was blocked by p115RGS or Galpha13. Our findings show that the actions of thrombin on the proliferation of RA SFs, cell-cycle progression to the S phase, and IL-6 secretion were mainly mediated by the G13 and RhoGEF pathways. These results suggest that p115RGS and Galpha13 could be potent inhibitors of such functions. A rational design of future therapeutic strategies for RA synovitis could perhaps include the exploitation of the Rho pathway to directly reduce the growth of synovial cells.

UR - http://www.scopus.com/inward/record.url?scp=33644811654&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644811654&partnerID=8YFLogxK

M3 - Article

C2 - 15899034

AN - SCOPUS:33644811654

VL - 7

JO - Arthritis Research and Therapy

JF - Arthritis Research and Therapy

SN - 1478-6354

IS - 3

ER -